Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer

Lindsay L. Peterson, Jennifer L. Ligibel

Research output: Contribution to journalReview articlepeer-review

Abstract

One in five women with breast cancer will relapse despite ideal treatment. Body weight and physical activity are strongly associated with recurrence risk, thus lifestyle modification is an attractive strategy to improve prognosis. Trials of dietary modification in breast cancer are promising but the role of specific diets is unclear, as is whether high-quality diet without weight loss can impact prognosis. Advanced glycation end-products (AGEs) are compounds produced in the body during sugar metabolism. Exogenous AGEs, such as those found in food, combined with endogenous AGEs, make up the total body AGE load. AGEs deposit in tissues over time impacting cell signaling pathways and altering protein functions. AGEs can be measured or estimated in the diet and measured in blood through their metabolites. Studies demonstrate an association between AGEs and breast cancer risk and prognosis. Here, we review the clinical data on dietary and serum AGEs in breast cancer.

Original languageEnglish
Article number188995
JournalBiochimica et Biophysica Acta - Reviews on Cancer
Volume1879
Issue number1
DOIs
StatePublished - Jan 2024

Keywords

  • Advanced glycation end-products
  • Biomarker
  • Breast cancer
  • Diet
  • Lifestyle

Fingerprint

Dive into the research topics of 'Dietary and serum advanced glycation end-products and clinical outcomes in breast cancer'. Together they form a unique fingerprint.

Cite this